微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | -3.44% | -194.77% | -36.51% | 127/159 | 4.18% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-06-30 | -2.52% | -203.7% | -215.07% | 127/159 | 2.63% | 百利天恒 | 181.27% | 行业排名> |
| 2024-03-31 | 2.19% | -14.12% | 546.94% | 54/159 | 2.32% | 百利天恒 | 186.1% | 行业排名> |
| 2023-12-31 | -0.49% | -104.53% | -113.5% | 106/159 | -1.03% | 百利天恒 | 186.89% | 行业排名> |
| 2023-09-30 | 3.63% | -77.93% | 49.38% | 85/159 | 2.35% | 百利天恒 | 188.56% | 行业排名> |
| 2023-06-30 | 2.43% | -75.8% | -4.71% | 76/159 | 1.47% | 小方制药 | 41.8% | 行业排名> |
| 2023-03-31 | 2.55% | -58.67% | -76.43% | 48/159 | 1.38% | 拓新药业 | 20.51% | 行业排名> |
| 2022-12-31 | 10.82% | -37.85% | -34.22% | 42/159 | 0.74% | 拓新药业 | 19.87% | 行业排名> |
| 2022-09-30 | 16.45% | -7.32% | 63.84% | 6/159 | 2.89% | 拓新药业 | 19.91% | 行业排名> |
| 2022-06-30 | 10.04% | -2.14% | 62.72% | 11/159 | 2.22% | 小方制药 | 55.57% | 行业排名> |
| 2022-03-31 | 6.17% | 9.98% | -64.56% | 7/159 | 1.61% | 福元医药 | 25.41% | 行业排名> |
| 2021-12-31 | 17.41% | -22.35% | -1.92% | 13/159 | 0.87% | 小方制药 | 34.81% | 行业排名> |
| 2021-09-30 | 17.75% | -30.39% | 73% | 5/159 | 4.53% | 退市金泰 | 10.74% | 行业排名> |
| 2021-06-30 | 10.26% | -9.2% | 82.89% | 15/159 | 2.99% | 人福医药 | 6.82% | 行业排名> |
| 2021-03-31 | 5.61% | -28.81% | -74.98% | 7/159 | 2.52% | 小方制药 | 71.99% | 行业排名> |
| 2020-12-31 | 22.42% | -19.76% | -12.08% | 16/159 | 3.71% | 汇宇制药 | 39.25% | 行业排名> |
| 2020-09-30 | 25.5% | 20.11% | 125.66% | 4/159 | 3.22% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-06-30 | 11.3% | -8.8% | 43.4% | 14/159 | 4.24% | 哈三联 | 27.17% | 行业排名> |
| 2020-03-31 | 7.88% | 0% | -71.8% | 5/159 | 2.24% | 汇宇制药 | 55.94% | 行业排名> |
| 2019-12-31 | 27.94% | 30.38% | 31.61% | 9/159 | 2.71% | 河化股份 | 45.32% | 行业排名> |
| 2019-09-30 | 21.23% | 35.48% | 71.35% | 4/159 | 7.61% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-06-30 | 12.39% | 36.45% | 57.23% | 8/159 | 5.02% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-03-31 | 7.88% | 94.09% | -63.23% | 6/159 | 2.46% | 奥赛康 | 35% | 行业排名> |
| 2018-12-31 | 21.43% | 46.38% | 36.76% | 13/159 | 7.09% | 奥赛康 | 28.15% | 行业排名> |
| 2018-09-30 | 15.67% | 56.08% | 72.58% | 9/159 | 7.26% | 宏源药业 | 21.91% | 行业排名> |
| 2018-06-30 | 9.08% | 44.82% | 123.65% | 14/159 | 4.65% | 奥赛康 | 9.7% | 行业排名> |
| 2018-03-31 | 4.06% | 21.92% | -72.27% | 16/159 | 2.55% | 奥赛康 | 40.69% | 行业排名> |
| 2017-12-31 | 14.64% | -33.61% | 45.82% | 28/159 | 9.66% | 信立泰 | 25.93% | 行业排名> |
| 2017-09-30 | 10.04% | 2% | 60.13% | 29/159 | 8.31% | 昂利康 | 15.91% | 行业排名> |
| 2017-06-30 | 6.27% | -20.93% | 88.29% | 31/159 | 5.59% | 奥赛康 | 12.08% | 行业排名> |
| 2017-03-31 | 3.33% | 2% | -84.9% | 21/159 | 2.1% | 一品红 | 31.62% | 行业排名> |
| 2016-12-31 | 22.05% | 15.51% | 178.06% | 18/159 | 6.33% | 丽珠集团 | 49.43% | 行业排名> |
| 2016-06-30 | 7.93% | 10.14% | -58.46% | 24/159 | 3.53% | 河化股份 | 54.24% | 行业排名> |
| 2015-12-31 | 19.09% | 26.76% | 165.14% | 23/159 | 11.35% | 华东医药 | 7.2% | 行业排名> |
| 2015-06-30 | 7.2% | 2% | -52.19% | 23/159 | 4.9% | 南新制药 | 81.7% | 行业排名> |